Monthly Archives: April 2020

Hyperkeratotic hand eczema: Eczema or not?

CONCLUSION: Currently, the phenotype of HHE is included in the hand eczema classification system; however, it can be argued whether this is justified. The evident expression of filaggrin and involucrin in lesional skin does not support a pathogenesis of atopic eczema. The upregulation of K6, K16, and K17 and reduction of K9 and K14 might contribute to the underlying pathogenesis. Unfortunately, comparison with hand eczema studies is not possible yet, because similar protein expression studies… Continue reading






Comments Off on Hyperkeratotic hand eczema: Eczema or not?

Giant Arcuate Lupus Vulgaris with Rapid Progression: A Case Report

Lupus vulgaris is the commonest form of cutaneous tuberculosis. It is a chronic and slowly progressive disease. It can be transmitted either through hematogenous or lymphatic spread but most commonly through contiguous extension.There are many reports on different form of lupus vulgaris but there are only a few reports on large sized lupus vulgaris. Here, we report a case of 75-year-old man with a giant lupus vulgaris rapidly progressing in just two year’s duration. Keywords: cutaneous… Continue reading






Comments Off on Giant Arcuate Lupus Vulgaris with Rapid Progression: A Case Report

Pseudo-wound infection after a caesarean section: Case report of unrecognized Pyoderma Gangrenosum

CONCLUSION: Post-operative PG can mimic infectious diseases, but treatment is substantially different. This case of extensive PG highlights the importance of timely recognition and treatment of the disease to reduce iatrogenic morbidity. Continue reading






Comments Off on Pseudo-wound infection after a caesarean section: Case report of unrecognized Pyoderma Gangrenosum

Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry

No abstract Continue reading






Comments Off on Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry

Protocol for the development of a core domain set for hand eczema trials

BACKGROUND: Clinical hand eczema trials measure a variety of outcome domains to determine the success of interventions. This considerably limits the comparability and overall confidence in the study results, and thereby the strength of recommendations for clinical practice. Continue reading






Comments Off on Protocol for the development of a core domain set for hand eczema trials